Sepul Bio begins clinical trial of ultevursen for USH2A-associated RP
Sepul Bio begins clinical trial of ultevursen for USH2A-associated RP
Search results
Sepul Bio begins clinical trial of ultevursen for USH2A-associated RP
Mirugen – Unlocking the Power of Retina Regeneration
Research determines that taking high dose vitamin A supplements does not slow vision loss in people with retinitis pigmentosa (RP).
There are many ongoing clinical and laboratory studies around the world, exploring innovative approaches to treating inherited sight loss.
Despite the knock-on effects of the pandemic, there’s been a lot going on this year in the world of research! Here are snapshots of a few stories that have appeared in the Research News section of our website in 2022.
UK researchers have discovered that passing a weak electrical current between electrodes on a person’s scalp may lead to a reduction in frequency of the visual hallucinations experienced by some people living with sight loss.
Several groups around the world are investigating the use of retinal transplantation in the treatment of inherited retinal diseases.
Please read our conditions of use carefully as by using the website you will be assumed to have agreed to be bound by them.
Our monthly e-Newsletter featuring the latest updates from Retina UK. Subscribe now to receive these updates directly to your email.
The cover of this edition celebrates the success of our amazing London Marathon team. Together they have raised more than £43,000.